MGC Pharmaceuticals Enters Partnership with Sciensus Rare for Distribution of Cannabinoids to Treat Refractory Epilepsy, Dementia and Alzheimer's in the EU and

LONDON, April 5, 2022 /PRNewswire/ – MGC Pharmaceuticals Ltd. (LSE: MXC, ASX: MXC, OTC:MGCLF), a European based bio-pharma company specializing in...

Related Keywords

Australia ,United States ,Denmark ,Netherlands ,United Kingdom ,Brazil ,Luxembourg ,Italy ,Perth ,Western Australia ,Ireland ,Spain ,France ,London ,City Of ,Tavistock ,Devon ,America ,Turner Pope ,Andy Thacker James Pope ,Roby Zomer ,Charles Vivian Tim Pearson ,David Lim ,Gareth Williams ,Instagram ,Linkedin ,Twitter ,Science International ,Ireland Medical Cannabis Access Programme ,Pharmaceuticals Ltd ,University Of Notre Dame ,Facebook ,Sciensus Rare ,Drug Resistant Epilepsy ,Market Authorization ,Early Access Programmes ,Named Patient ,Managing Director ,Western Europe ,Investigational Medicinal Product ,Medical Cannabis Access ,Notre Dame ,North America ,Kingdom Broker ,